Skip to main content

Pharmacists and the COVID-19 Pandemic

Call for Papers: Thematic series on COVID-19

Given the current global pandemic, the Journal of Pharmaceutical Policy and Practice would like to announce a Call for Papers for a special series on COVID-19. 

The journal seeks works related to prevention, newer treatments, medicines safety, medicines quality and shortages, pharmaceutical policy and practice, pharmacists and pharmacy services, information and dissemination, as well as technology aspects of COVID-19. 

Submissions are welcome on the following topics:

  • Pharmacists and pharmacy services
  • Medicines use and safety aspects of investigational medicines including antivirals, antimalarials, chloroquine, hydroxychloroquine, and other medicines
  • Importance of reliable independent sources of information with regards to prevention, treatment, and medicines use
  • The role of technology and pharmacy services
  • Pharmacists’ response towards COVID-19, including prevention, mitigation, treatment, and the role of pharmacy services
  • Medicines safety, quality, and shortages
  • Country-specific case studies on pharmacy and COVID-19

You can submit your work to the journal here.

  1. Vaccine hesitancy poses a global challenge and is acknowledged to be a complex, multifactorial phenomenon. Of particular concern is hesitancy among health professionals, as this may also impact their advocacy ...

    Authors: Moza Al Hail, Pallivalapila Abdulrouf, Derek Stewart, Wessam Elkassem, Rajvir Singh, Rasha Al Enany, Aftab Mohammed Azad, Asma Tarannum and Binny Thomas
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:160
    Content type: Research Published on:

  2. COVID-19 pandemic has created challenges to the ward pharmacy practice. Challenges arose due to new norms in the ward pharmacy practice. Adaptive measures to overcome these challenges were important to sustain...

    Authors: Chew Beng Ng, You Leng Tan, Ros Sakinah Kamaludin, Chee Tao Chang, Chii-Chii Chew, Wai Keng Foong, Siew Huang Lee, Normi Hamdan and Su Yin Ong
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:85
    Content type: Short report Published on:

  4. In Indonesia, the world's fourth most populous country, cardiovascular diseases (CVDs) are a leading cause of death and disability. Government efforts to reduce the burden of CVD include a community-based prev...

    Authors: Aksari Dewi, Elizabeth Pisani, Bachtiar Rifai Pratita Ihsan, Ayuk Lawuningtyas Hariadini, Anushka Patel, Anna Palagyi, Devarsetty Praveen, Sujarwoto and Diana Lyrawati
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:50
    Content type: Research Published on:

  5. In many low- and middle-income countries, the 2019 novel coronavirus (COVID-19) has challenged efforts to ensure access to and availability of quality maternal, newborn, and child health (MCH) services and ess...

    Authors: Tsegaye Melaku, Desta Assefa, Fanta Gashe, Mestawet Getachew, Temesgen Kabeta and Zeleke Mekonnen
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:35
    Content type: Research Published on:

  6. Home isolation has been proposed for coronavirus disease 2019 (COVID-19) patients with mild symptoms to avoid hospital overcrowding. This study aimed to describe the drug-related problems (DRPs) and the pharma...

    Authors: Worapong Sungsana, Chotirat Nakaranurack, Benjabhorn Weeraphon, Watsa Charoenwaiyachet, Supparat Chanprasert, Pattama Torvorapanit, Wichai Santimaleeworagun and Opass Putcharoen
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:29
    Content type: Research Published on:

  7. Health supply chain is crucial for proper functioning of a health system and advancing national and international health security goals. The Coronavirus 2019 pandemic caused major challenges for health supply ...

    Authors: John Hans Wasswa, Henry Oundo, Martin Olowo Oteba, Henry Komakech, Irene Ochola, Sheila Mwebaze, Denis Okidi, Anthony Kirunda, Shamim Nakadde, Neville Okuna Oteba and Eric Lugada
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:6
    Content type: Review Published on:

  8. Older adults are among the most vulnerable groups during the COVID-19 epidemic, contributing to a large proportion of COVID-19-related death. Medication review and reconciliation by pharmacist can help reduce ...

    Authors: Chee-Tao Chang, Siti Mallissa Mohd Shariff, Nur Suriana Abu Bakar, Nasiha Sufina Ramzuzzaman, Chun Kiat Lim, Eddy Yew Joe Lim, Peng Seng Ong, Jie Min Lee, Aie Yen Tan, Siti Fatimah Kamis, Wei Mun Liew, Yuet Man Low, Doris George, James Yau Hon Voo, Hoo Seng Tan, Philip Rajan…
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:2
    Content type: Short report Published on:

  9. Coronavirus disease (COVID-19) pandemic posed a critical threat to public health in the past year and has not been fully controlled so far. The nature of front-line young hospital pharmacists’ occupation puts ...

    Authors: Jiahao Wu, Jian Cai, Ming Fang, Yan Wang and Feng Xu
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:66
    Content type: Research Published on:

  10. This commentary shares the experience of a hospital pharmacy department in providing healthcare services during the COVID-19 outbreak in Malaysia. During this pandemic, the medication delivery system is redesi...

    Authors: Kah Shuen Thong, Manimegahlai Selvaratanam, Chiew Ping Tan, Meng Fei Cheah, Hoey Lin Oh, Pooi Mun Lee, Chii-Chii Chew, Chee-Tao Chang and Jason Choong Yin Lee
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:61
    Content type: Commentary Published on:

  12. Adequate quality systems throughout pharmaceutical supply chains are crucial to protect individuals and communities from substandard and falsified medical products. Thus, pharmaceutical distributors are regula...

    Authors: Anthony Bourasseau, Laurine Lavergne and Raffaella Ravinetto
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:43
    Content type: Research Published on:

  13. Over the last year, the dangerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly around the world. Malaysia has not been excluded from this COVID-19 pandemic. The resurgence of...

    Authors: Ching Siang Tan, Saim Lokman, Yao Rao, Szu Hua Kok and Long Chiau Ming
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:40
    Content type: Commentary Published on:

  14. Since the WHO announced that Covid-19 had become a global pandemic, online pharmacies have emerged as an extremely popular way to purchase medication due to the quarantine measures introduced by numerous count...

    Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Naseem Mohammed Abdulla, Faris El-Dahiyat, Maimona Jairoun, Saleh Karamah AL-Tamimi and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:38
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2021 14:44

  17. COVID-19 is a threat to health systems around the world and Rwanda is not an exception. The impact of the pandemic is far-reaching and access to health commodities is not spared. Proper drug supply is critical...

    Authors: Theogene Uwizeyimana, Hashim Talib Hashim, Jean Damascene Kabakambira, Jean Claude Mujyarugamba, Jackson Dushime, Blaise Ntacyabukura, Remy Ndayizeye, Yusuff Adebayo Adebisi and Don Eliseo Lucero-Prisno III
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:12
    Content type: Commentary Published on:

  18. The declaration of COVID-19 a pandemic by the World Health Organization on 11 March 2020 marked the beginning of a global health crisis of an unprecedented nature and scale. The approach taken by countries acr...

    Authors: Diane Ashiru-Oredope, Amy Hai Yan Chan, Omotayo Olaoye, Victoria Rutter and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:72
    Content type: Research Published on:

  19. Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The nature of healthcare providers’ occupation puts them at an increased risk of getting any contagious disease...

    Authors: Abdullah Algunmeeyn, Faris El-Dahiyat, Mohammad Mitib Altakhineh, Mohammad Azab and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:53
    Content type: Research Published on:

  20. With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the favorable therapeutic candidates with potential antivira...

    Authors: Vesa Halimi, Armond Daci, Nevenka Ridova, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, Aleksandar Dimovski and Aleksandra Grozdanova
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:61
    Content type: Commentary Published on:

  21. During the COVID-19 pandemic, the Lebanese government has taken the proactive anticipatory measure to minimize the infection rates. Despite the pivotal role of the pharmacists working in hospital settings, hos...

    Authors: Rony M. Zeenny, Elsy Ramia, Youssef Akiki, Souheil Hallit and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:54
    Content type: Research Published on:

  22. The COVID-19 pandemic has unleashed unprecedented and complex public policy issues. One that has emerged as a challenge for many countries globally is how to ensure the efficient and effective procurement of q...

    Authors: Jillian Clare Kohler and Tom Wright
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:58
    Content type: Commentary Published on:

  23. Since SARS-CoV2 was declared a Public Health Emergency of International Concern, those tasked with the stewardship of public health at a global, regional, and local level—policymakers, politicians, scientists, dr...

    Authors: Jerome Amir Singh and Rafaella Ravinetto
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:47
    Content type: Commentary Published on:

  24. The coronavirus disease 2019 (COVID-19) impact on the mental health of healthcare workers is extremely detrimental. It is imperative that the psychological health of all healthcare workers be protected. Howeve...

    Authors: Ali Elbeddini, Cindy Xin Wen, Yasamin Tayefehchamani and Anthony To
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:46
    Content type: Commentary Published on:

  25. Drug repositioning is the scientific strategy of investigating existing drugs for additional clinical indications. The advantages of drug repositioning are that it benefits patients and that it adds new indica...

    Authors: A. B. Bayoumy, N. K. H. de Boer, A. R. Ansari, F. Crouwel and C. J. J. Mulder
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:45
    Content type: Review Published on:

  26. The novel coronavirus disease 2019 (COVID-19) pandemic is a global challenge. Improving public awareness about preventive measures and disseminating appropriate information about COVID-19 has a critical role i...

    Authors: Ruwidah Bonyan, Aseel Fuad Al-Karasneh, Faris El-Dahiyat and Ammar Abdulrahman Jairoun
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:43
    Content type: Research Published on:

  27. Coronavirus disease 2019 (COVID-19) is an infectious disease that has become a global pandemic. COVID-19 is spreading in Africa, and Zimbabwe has not been spared. The cases in Zimbabwe are mainly from imported...

    Authors: B. Dzingirai, C. M. J. Matyanga, T. Mudzviti, M. Siyawamwaya and D. Tagwireyi
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:42
    Content type: Review Published on:

  28. The latest outbreak of Covid-19 pandemic has placed a significant effect on health care system around the world. This article discusses the role of pharmacists in Saudi Arabia during the current Covid-19 pande...

    Authors: Ajaz Ahmad, Khalid M. Alkharfy, Ziyad Alrabiah and Abdulaziz Alhossan
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:41
    Content type: Commentary Published on:

  29. The response to emergency public health challenges such as HIV, TB, and malaria has been successful in mobilising resources and scaling up treatment for communicable diseases. However, many of the remaining ch...

    Authors: Tamara Hafner, Marlon Banda, Jillian Kohler, Zaheer-Ud-Din Babar, Murray Lumpkin, Mojisola Christianah Adeyeye, Emmanuel Nfor, Francis Aboagye-Nyame and Javier Guzman
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:38
    Content type: Commentary Published on:

  30. In the fight against COVID-19, frontline health workers have been vital to keeping the pandemic at bay, but recognition of individual professions’ efforts have been inconsistent at all levels. Pharmacists arou...

    Authors: Ali Elbeddini, Thulasika Prabaharan, Sarah Almasalkhi and Cindy Tran
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:36
    Content type: Commentary Published on:

  31. SARS-CoV2 is dramatically impacting the global population. Worldwide, pharmacists are changing their roles and being increasingly recognized for their role as essential service providers. This commentary provi...

    Authors: Filipa Alves da Costa, Vivian Lee, Silvana Nair Leite, Maria Dolores Murillo, Tom Menge and Sotiris Antoniou
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:12
    Content type: Commentary Published on:

  33. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Ali Elbeddini, Aniko Yeats and Stephanie Lee
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:30
    Content type: Correction Published on:

    The original article was published in Journal of Pharmaceutical Policy and Practice 2020 13:18

  34. The coronavirus disease (COVID-19) pandemic has placed enormous pressures on the Canadian healthcare system. Patients are expected to stay home in order to contain the spread of the virus, but understandably h...

    Authors: Ali Elbeddini and Aniko Yeats
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:23
    Content type: Commentary Published on:

  36. Amid COVID-19 Crisis, reporting adverse drug reactions (ADRs) and medical device incidents (MDIs) to Health Canada or health authorities in every country is crucial for monitoring medication safety and improving ...

    Authors: Ali Elbeddini, Aniko Yeats and Stephanie Lee
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:18
    Content type: Commentary Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2020 13:30

  37. This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinica...

    Authors: Vesa Halimi, Armond Daci, Simona Stojanovska, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce and Aleksandra Grozdanova
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:16
    Content type: Commentary Published on:

  38. There is plenty of evidence to support that women leaders are needed in the health and pharmaceutical sectors, although most of the leadership positions in global health are predominantly occupied by men. This...

    Authors: Nadia Bukhari, Mehr Manzoor, Huma Rasheed, Bismah Nayyer, Madeeha Malik and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:15
    Content type: Commentary Published on:

  39. The world currently faces unprecedented health challenges as COVID-19 poses a huge threat to health systems, economies and societies as we know it. The events of the current COVID-19 pandemic have further emph...

    Authors: Amy Hai Yan Chan, Victoria Rutter, Diane Ashiru-Oredope, Chloe Tuck and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:13
    Content type: Commentary Published on:

  40. As the lockdowns are being observed all over the globe and the national level pharmacy professionals are performing frontline roles, this editorial highlights the role of pharmacists in the COVID − 19 pandemic...

    Authors: Nadia Bukhari, Huma Rasheed, Bismah Nayyer and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:8
    Content type: Editorial Published on: